Back
Kiora Pharmaceuticals, Inc. 10K Form
Sell
36
KPRX
Kiora Pharmaceuticals, Inc.
Last Price:
$2.12
Seasonality Move:
2.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KPRX News And Ratings
See the #1 stock for the next 7 days that we like better than KPRX
KPRX Financial Statistics
Sales & Book Value
| Annual Sales: | $16M |
|---|---|
| Cash Flow: | $-1.3M |
| Price / Cash Flow: | 1.15 |
| Annual Sales: | $6.53 |
| Price / Book: | 0.35 |
Profitability
| EPS (TTM): | -2.46090 |
|---|---|
| Net Income (TTM): | $-8.5M |
| Gross Margin: | $16M |
| Return on Equity: | -34.44% |
| Return on Assets: | -25% |
Kiora Pharmaceuticals, Inc. Earnings Forecast
Key Kiora Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for KPRX is 99.59%.
-
The Selling, General & Administrative Expenses for KPRX have been equal to 34.60% of Gross Profit Margin.
-
The Research & Development expenses have been 48.95% of Revenue.
-
The Interest Expense is 0.60% of Operating Income.
-
The Net Earning history of KPRX is 22.44% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 11 years.
Kiora Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | KPRX |
| Website: | kiorapharma.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 8.79 |
| Quick Ratio: | 7.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.47 |
|---|---|
| Forward P/E Ratio: | 0 |
KPRX Technical Analysis vs Fundamental Analysis
Sell
36
Kiora Pharmaceuticals, Inc. (KPRX)
is a Sell
Is Kiora Pharmaceuticals, Inc. a Buy or a Sell?
-
Kiora Pharmaceuticals, Inc. stock is rated a SellThe current Kiora Pharmaceuticals, Inc. [KPRX] share price is $2.15. The Score for KPRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.